FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Basel
State: Basel-Stadt
Zip:
Country: Switzerland
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Grant | 1 | $1M |
InnoSuisse InnoSuisse |
7/2022 | Grant | 1 | $152.9k |
Venture Kick Venture Kick |
9/2022 | Convertible Note | 1 | $494.9k |
BioInnovation Institute BioInnovation Institute |
2/2022 | Grant | 1 | $162k |
InnoBooster InnoBooster |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|